Journal of Pharmacological Sciences | |
Effects of Atorvastatin, Amlodipine, and Their Combination on Vascular Dysfunction in Insulin-Resistant Rats | |
Kazuya Shinozaki2  Yuichi Yoshida3  Ayman Geddawy2  Haruo Shintaku1  Tomio Okamura2  Hirotaka Iwasaki2  Masashi Tawa2  Takashi Shimosato2  Takeshi Imamura2  Masahiro Masada3  | |
[1] Department of Pediatrics, Osaka City University Graduate School of Medicine, Japan;Department of Pharmacology, Shiga University of Medical Science, Japan;Laboratory of Biochemistry, Faculty of Horticulture, Chiba University, Japan | |
关键词: 3-hydroxyl-3-methylglutaryl coenzyme A reductase inhibitor; calcium antagonist; nitric oxide; tetrahydrobiopterin; insulin resistance; | |
DOI : 10.1254/jphs.13178FP | |
学科分类:药学 | |
来源: Nihon Yakuri Gakkai Henshuubu / Japanese Pharmacological Society | |
【 摘 要 】
References(41)Cited-By(6)Deficiency of tetrahydrobiopterin (BH4) in the vascular tissue contributes to endothelial dysfunction through reduced eNOS activity and increased superoxide anion (O2�?) generation in the insulin-resistant state. We investigated the effects of atorvastatin, a 3-hydroxyl-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibitor; amlodipine, a calcium antagonist; and their combination on blood pressure, arterial relaxation and contraction, and vascular oxidative stress in aortas of high fructose–fed rats. Oral administration of atorvastatin for 8 weeks did not significantly lower blood pressure, but normalized angiotensin II–induced vasoconstriction and endothelial function in the fructose-fed rats. Atorvastatin treatment of fructose-fed rats increased vascular BH4 content, which was associated with an increase in endothelial NO synthase activity as well as a reduction in endothelial O2�? production. On the other hand, administration of amlodipine did not affect the angiotensin II–induced vasoconstriction and endothelial function, but normalized the elevated blood pressure in the fructose-fed rats. The combined treatment did not show synergistic but additive beneficial effects. The present study suggests that combined therapy of HMG-CoA reductase inhibitors and calcium antagonists prevents functional vascular disorders in the insulin-resistant state, possibly resulting in the protection against or delay of development of hypertension, vascular dysfunction in diabetes, and thereafter atherosclerosis.
【 授权许可】
Unknown
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO201911300047703ZK.pdf | 1287KB | download |